1-[3-[3-(3-hydroxynaphthalen-1-yl)isoquinolin-7-yl]azetidin-1-yl]prop-2-en-1-one;3-(3-hydroxynaphthalen-1-yl)-7-(1-prop-2-enoylazetidin-3-yl)-1,4-dihydroquinazolin-2-one;3-(5-methyl-1H-indazol-4-yl)-7-(1-prop-2-enoylazetidin-3-yl)-1,4-dihydroquinazolin-2-one;2-(5-methyl-1H-indazol-4-yl)-6-(1-prop-2-enoylazetidin-3-yl)isoquinolin-3-one
C94H82N14O9 — CID 157299621
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-[3-[3-(3-hydroxynaphthalen-1-yl)isoquinolin-7-yl]azetidin-1-yl]prop-2-en-1-one;3-(3-hydroxynaphthalen-1-yl)-7-(1-prop-2-enoylazetidin-3-yl)-1,4-dihydroquinazolin-2-one;3-(5-methyl-1H-indazol-4-yl)-7-(1-prop-2-enoylazetidin-3-yl)-1,4-dihydroquinazolin-2-one;2-(5-methyl-1H-indazol-4-yl)-6-(1-prop-2-enoylazetidin-3-yl)isoquinolin-3-one
1-[3-[3-(3-hydroxynaphthalen-1-yl)isoquinolin-7-yl]azetidin-1-yl]prop-2-en-1-one;3-(3-hydroxynaphthalen-1-yl)-7-(1-prop-2-enoylazetidin-3-yl)-1,4-dihydroquinazolin-2-one;3-(5-methyl-1H-indazol-4-yl)-7-(1-prop-2-enoylazetidin-3-yl)-1,4-dihydroquinazolin-2-one;2-(5-methyl-1H-indazol-4-yl)-6-(1-prop-2-enoylazetidin-3-yl)isoquinolin-3-one (PubChem CID 157299621) has the molecular formula C94H82N14O9 and a molecular weight of 1551.78 g/mol. Its IUPAC name is 1-[3-[3-(3-hydroxynaphthalen-1-yl)isoquinolin-7-yl]azetidin-1-yl]prop-2-en-1-one;3-(3-hydroxynaphthalen-1-yl)-7-(1-prop-2-enoylazetidin-3-yl)-1,4-dihydroquinazolin-2-one;3-(5-methyl-1H-indazol-4-yl)-7-(1-prop-2-enoylazetidin-3-yl)-1,4-dihydroquinazolin-2-one;2-(5-methyl-1H-indazol-4-yl)-6-(1-prop-2-enoylazetidin-3-yl)isoquinolin-3-one.
Molecular Properties
| Compound Name | 1-[3-[3-(3-hydroxynaphthalen-1-yl)isoquinolin-7-yl]azetidin-1-yl]prop-2-en-1-one;3-(3-hydroxynaphthalen-1-yl)-7-(1-prop-2-enoylazetidin-3-yl)-1,4-dihydroquinazolin-2-one;3-(5-methyl-1H-indazol-4-yl)-7-(1-prop-2-enoylazetidin-3-yl)-1,4-dihydroquinazolin-2-one;2-(5-methyl-1H-indazol-4-yl)-6-(1-prop-2-enoylazetidin-3-yl)isoquinolin-3-one |
|---|---|
| PubChem CID | 157299621 |
| Molecular Formula | C94H82N14O9 |
| Molecular Weight | 1551.78 g/mol |
| Exact Mass | 1550.64 |
| IUPAC Name | 1-[3-[3-(3-hydroxynaphthalen-1-yl)isoquinolin-7-yl]azetidin-1-yl]prop-2-en-1-one;3-(3-hydroxynaphthalen-1-yl)-7-(1-prop-2-enoylazetidin-3-yl)-1,4-dihydroquinazolin-2-one;3-(5-methyl-1H-indazol-4-yl)-7-(1-prop-2-enoylazetidin-3-yl)-1,4-dihydroquinazolin-2-one;2-(5-methyl-1H-indazol-4-yl)-6-(1-prop-2-enoylazetidin-3-yl)isoquinolin-3-one |
| SMILES | C=CC(=O)N1CC(c2ccc3c(c2)NC(=O)N(c2c(C)ccc4[nH]ncc24)C3)C1.C=CC(=O)N1CC(c2ccc3c(c2)NC(=O)N(c2cc(O)cc4ccccc24)C3)C1.C=CC(=O)N1CC(c2ccc3cc(-c4cc(O)cc5ccccc45)ncc3c2)C1.C=CC(=O)N1CC(c2ccc3cn(-c4c(C)ccc5[nH]ncc45)c(=O)cc3c2)C1 |
| InChI | InChI=1S/C25H20N2O2.C24H21N3O3.C23H20N4O2.C22H21N5O2/c1-2-25(29)27-14-20(15-27)16-7-8-17-11-24(26-13-19(17)9-16)23-12-21(28)10-18-5-3-4-6-22(18)23;1-2-23(29)26-12-18(13-26)15-7-8-17-14-27(24(30)25-21(17)10-15)22-11-19(28)9-16-5-3-4-6-20(16)22;1-3-21(28)26-11-18(12-26)15-5-6-16-13-27(22(29)9-17(16)8-15)23-14(2)4-7-20-19(23)10-24-25-20;1-3-20(28)26-10-16(11-26)14-5-6-15-12-27(22(29)24-19(15)8-14)21-13(2)4-7-18-17(21)9-23-25-18/h2-13,20,28H,1,14-15H2;2-11,18,28H,1,12-14H2,(H,25,30);3-10,13,18H,1,11-12H2,2H3,(H,24,25);3-9,16H,1,10-12H2,2H3,(H,23,25)(H,24,29) |
| InChIKey | BBTCBNRXKDZBKY-UHFFFAOYSA-N |
| XLogP | 15.90 |
| TPSA | 278.63 Ų |
| H-Bond Donors | 6 |
| H-Bond Acceptors | 13 |
| Rotatable Bonds | 12 |
| Heavy Atoms | 117 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1551.78 |
| LogP ≤ 5 | 15.90 |
| H-Bond Donors ≤ 5 | 6 |
| H-Bond Acceptors ≤ 10 | 13 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 157299621 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.